⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120857 | 1.00 | — | — | |
| SCHEMBL2121208 | 0.79 | — | — | |
| SCHEMBL2121203 | 0.79 | — | — | |
| SCHEMBL5154265 | 0.76 | — | — | |
| SCHEMBL7164192 | 0.76 | — | — | |
| SCHEMBL2121141 | 0.76 | — | — | |
| SCHEMBL2121145 | 0.76 | — | — | |
| SCHEMBL2118705 | 0.75 | TSHR (0.32) | — | |
| SCHEMBL2118704 | 0.75 | TSHR (0.32) | — | |
| SCHEMBL109866 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693603-A | Bicyclic fused compounds for the treatment of inflammatory diseases and uses thereof | 南京知和医药科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230250218-A1 | URETHANE COMPOSITION | NITTO KASEI CO., LTD. (JP) | 2023-08-10 | — | — | US | disclosed |
| EP-4198068-A1 | URETHANE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-116135871-A | Antibacterial compound with drug resistance | 石家庄迪斯凯威医药科技有限公司 | 2023-05-19 | — | — | CN | disclosed |
| CN-116018365-A | Carbamate composition | 日东化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| EP-3986394-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2022-04-27 | — | — | EP | disclosed |
| WO-2020252535-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2020-12-24 | — | — | WO | disclosed |
| EP-2444401-B1 | NOVEL IMIDAZOPYRIDINE COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2014-09-03 | — | — | EP | disclosed |
| CN-101720317-B | Process for producing difluoromethyl-substituted pyrazole compound | BASF SE | 2014-07-09 | — | — | CN | disclosed |
| US-8569504-B2 | Imidazopyridine compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-10-29 | — | — | US | disclosed |
| CN-1102039-A | External skin therapeutic agent composition containing isocarbacyclin as active ingredient | TEIJIN LTD (JP) | 1995-04-26 | — | — | CN | disclosed |
| CN-1102038-A | External skin therapeutic agent composition containing prostacyclin as active ingredient | TEIJIN LTD (JP) | 1995-04-26 | — | — | CN | disclosed |
| CN-1101781-A | Pharmaceutical composition for treating cerebral thrombosis | TEIJIN LTD (JP) | 1995-04-19 | — | — | CN | disclosed |
| EP-0638312-A1 | DERMATOLOGIC PREPARATION COMPOSITION CONTAINING ISOCARBACYCLIN AS ACTIVE INGREDIENT | TEIJIN LIMITED (JP) | 1995-02-15 | — | — | EP | disclosed |
| EP-0634172-A1 | DERMATOLOGIC PREPARATION COMPOSITION CONTAINING PROSTACYCLIN AS ACTIVE INGREDIENT | TEIJIN LIMITED (JP) | 1995-01-18 | — | — | EP | disclosed |
| EP-0634171-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS | TEIJIN LIMITED (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-4139720-A | Process for the preparation of aldehydes | HOFFMANN-LA ROCHE INC. (US) | 1979-02-13 | — | — | US | disclosed |
| US-4123464-A | Process for the preparation of aldehydes | HOFFMANN-LA ROCHE INC. (US) | 1978-10-31 | — | — | US | disclosed |
| US-4073811-A | Process for the preparation of aldehydes | HOFFMANN-LA ROCHE INC. (US) | 1978-02-14 | — | — | US | disclosed |
| US-4016212-A | Process for the preparation of aldehydes | HOFFMANN-LA ROCHE INC. (US) | 1977-04-05 | — | — | US | disclosed |